КОМПЛЕКСНАЯ ХАРАКТЕРИСТИКА НАРУШЕНИЙ ПРИ СИНДРОМЕ ШЕРЕШЕВСКОГО-ТЕРНЕРА
##article.subject##:
Shereshevskiy Tyorner sindromi, X xromosoma, mozaiklik, karyotip##article.abstract##
Shereshevskiy-Tyorner sindromi eng keng tarqalgan xromosoma anomaliyalaridan biri bo'lib, u bitta xromosomaning to'liq yo'qligi yoki X xromosomalaridan birida nuqson mavjudligi bilan tavsiflanadi. Qizlarda xromosoma anomaliyalari natijasida tuxumdonlarning yetilish jarayoni buziladi, balog'atga etishish kechikishi yoki to'liq yo'qligi va natijada bepushtlikning rivojlanishi kuzatiladi. Ba'zi hollarda (ko'pincha 45,X/46,XY karyotipi bilan) gonadoblastoma rivojlanishi mumkin. Kamdan kam hollarda Shereshevskiy-Tyorner bilan og'rigan bemorlarda spontan balog'atga etishish kuzatiladi. STS bilan og'rigan yosh ayollarning pediatriyadan kattalar parvarishiga o'tishi maktabni tark etishning yuqori darajasi va etarli darajada kuzatilmasligi bilan tavsiflanadi, bu esa kasallik va o'limning oshishiga olib keladi.
Библиографические ссылки
Aso K., Koto S., Higuchi A. et al. Serum FSH level below 10 mIU/mL at twelve years old is an index of spontaneous and cyclical menstruation in Turner syndrome. Endocrine journal. 2010; 57(10): 909–913.
Birkebaek N., Cruger D., Hansen J. Fertility and pregnancy outcome in Danish women with Turner syndrome. Clin Genet 2002; 61: 359.
Bondy C. Pregnancy and cardiovascular risk for women with Turner syndrome. Women Health. 2015; 4: 1-9.
Bondy C., Turner T., Consensus S. et al. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2014; 92: 10-25.
Brun S., Berglund A., Mortensen K. et al. Blood pressure, sympathovagal tone, exercise capacity and metabolic status are linked in Turner syndrome. Clin Endocrinol (Oxf). 2019; 91(1): 148-155.
Bryman I., Sylven L., Berntorp K. et al. Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertility and sterility. 2011; 95(8): 2507–2510.
Carrel L., Willard H. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005; 434(7031): 400–404.
Chang S., Tucker T., Thorogood N., Brown C. Mechanisms of X-chromosome inactivation. Front Biosci 2006; 11: 852–866.
Clement-Jones M., Schiller S., Rao E. et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000; 9(5): 695–702.
Darendeliler F., Yes¸ilkaya E., Bereket A. et al. Growth curves for Turkish Girls with Turner syndrome: results of the Turkish Turner syndrome Study Group. J Clin Res Pediatr Endocrinol 2015; 7: 183–91.
Day G., Szvetko A., Griffiths L. et al. SHOX gene is expressed in vertebral body growth plates in idiopathic and congenital scoliosis: implications for the etiology of scoliosis in Turner syndrome. J Orthop Res. 2009; 27(6): 807-813.
Donadille B., Christin-Maitre S. Heart and Turner syndrome. Ann Endocrinol (Paris). 2021; 82(3-4): 135-140.
Donato B., Ferreira M. Cardiovascular risk in Turner syndrome. Rev Port Cardiol (Engl Ed). 2018; 37(7): 607-621.
Folsom L., Fuqua J. Reproductive Issues in Women with Turner Syndrome. Endocrinol Metab Clin North Am. 2015; 44(4): 723-737.
Gravholt C., Andersen N., Conway G. et al. International Turner Syndrome Consensus Group. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017; 177(3): G1-G70.
Gravholt C., Viuff M., Brun S. et al. Turner syndrome: mechanisms and management. Nat Rev Endocrinol. 2019; 15(10): 601-614.
Hadnott T., Gould H., Gharib A., Bondy C. Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience. Fertility and sterility. 2011; 95(7): 2251–2256.
Hagman A., Loft A., Wennerholm U. et al. Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study. Human reproduction. 2013; 28(6): 1598–1609.
Hovatta O. Ovarian function and in vitro fertilization (IVF) in Turner syndrome. Pediatric endocrinology reviews: PER. 2012; 9(Suppl 2): 713–717.
Hreinsson J., Otala M., Fridström M. et al. Follicles are found in the ovaries of adolescent girls with Turner's syndrome. J Clin Endocrinol Metab. 2002; 87(8): 3618-3623.
Hutaff-Lee C., Bennett E., Howell S., Tartaglia N. Clinical developmental, neuropsychological, and social-emotional features of Turner syndrome. Am J Med Genet C Semin Med Genet. 2019; 181(1): 126-134.
Karnis M. Fertility, pregnancy, and medical management of Turner syndrome in the reproductive years. Fertility and sterility. 2012; 98(4): 787–791.
Kesler S. Turner syndrome. Child Adolesc Psychiatr Clin N Am. 2007; 16(3): 709-722.
Kosteria I., Kanaka-Gantenbein C. Turner Syndrome: transition from childhood to adolescence. Metabolism. 2018; 86: 145-153.
Mondal S., Bhattacharjee R., Chowdhury S., Mukhopadhyay S. Heterogeneity of Karyotypes in Turner Syndrome. Indian J Pediatr. 2021; 88(2): 175.
Moonga S., Pinkhasov A., Singh D. Obsessive-Compulsive Disorder in a 19-Year-Old Female Adolescent with Turner Syndrome. J Clin Med Res. 2017; 9(12): 1026–1028.
Negreiros L., Bolina E., Guimaraes M. Pubertal development profile in patients with Turner syndrome. Journal of Pediatric Endocrinology and Metabolism 2014; 27: 845–849.
Oktay K., Bedoschi G., Berkowitz K. et al. Fertility preservation in women with turner syndrome: a comprehensive review and practical guidelines. J Ped Adolescent Gynecol 2016; 29: 409–416.
Pasquino A., Passeri F., Pucarelli I. et al. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome. The Journal of clinical endocrinology and metabolism. 1997; 82(6): 1810–1813.
Peeters S., Korecki A., Baldry S. et al. How do genes that escape from X-chromosome inactivation contribute to Turner syndrome? Am J Med Genet C Semin Med Genet. 2019; 181(1): 28-35.
Reynaud K., Cortvrindt R., Verlinde F. et al. Number of ovarian follicles in human fetuses with the 45,X karyotype. Fertility and sterility. 2004; 81(4):1112–1119.
Santi M., Flück C., Hauschild M. et al. Health behaviour of women with Turner Syndrome. Acta Paediatr. 2021; 110(8): 2424-2429.
Schoemaker M., Swerdlow A., Higgins C. et al United Kingdom Clinical Cytogenetics G. Mortality in women with turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab. 2008; 93(12): 4735-4742.
Tanaka T., Igarashi Y., Ozono K. et al. Frequencies of spontaneous breast development and spontaneous menarche in Turner syndrome in Japan. Clinical Pediatric Endocrinology. 2015; 24: 167–173.
Visser J., Hokken>Koelega A., Zandwijken G et al. Anti-Mullerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Human Reprod 2013; 28: 1899–907.
Wu H., Li H. Karyotype classification, clinical manifestations and outcome in 124 Turner syndrome patients in China. Ann Endocrinol (Paris). 2019; 80(1): 10-15.
